Tracey McLaughlin, MD, MS
Stanford University School of Medicine, Stanford, California

Dr. McLaughlin graduated from Stanford University with honors and distinction in Human Biology, obtained a MS in Public Health at UC Berkeley, MD at UC San Francisco, and an MS in Epidemiology at Stanford University. She completed her residency in Internal Medicine at SCVMC and her fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University School of Medicine. She trained with Dr. Gerald Reaven at Stanford University in the area of insulin resistance, obesity, and metabolism.  She is currently a clinician investigator who maintains an active clinic for patients with complicated type 1, type 2, or other forms of diabetes and hypoglcyemia. Her clinical research program includes studies on obesity, regional fat distribution, and the role of adipose tissue in promoting insulin resistance. She also conducts studies on the role of incretin hormones in glucose metabolism and postbariatric hypoglycemia, and the use of continuous glucose monitoring in individuals with prediabetes and type 2 diabetes.  She collaborates with Dr Michael Snyder in a number of studies utilizing multi-omics methods to define metabolic sub-phenotypes and precision diets for individuals with prediabetes and type 2 diabetes.